Interestingly, there were statistically significant increments in CD56dim NK cell activation marker CD69 C-type lectin (p = 0.038) (Figure 1e,f) and in CD56dim NK cells expressing the checkpoint molecule PD-1 (p = 0.040) in COVID-19 patients with respect to controls (Figure 1g,h). Here, CD69 is linked to COVID-19.